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Abstract 1 
The characteristics and electromechanical properties of conductive polymers 2 
together to their biocompatibility have boosted their application as a suitable 3 
tool in regenerative medicine and tissue engineering. However, conducting 4 
polymers as drug release materials are far from being ideal. A possibility to 5 
overcome this drawback is to combine conducting polymers with on-command 6 
delivery particles with inherent high-loading capacity. In this scenario, we report 7 
here the preparation of conduction polymers containing gated mesoporous 8 
silica nanoparticles (MSN) loaded with a cargo that is delivered on command by 9 
electro-chemical stimuli increasing the potential use of conducting polymers as 10 
controlled delivery systems. MSNs are loaded with Rhodamine B (Rh B), 11 
anchored to the conductive polymer poly(3,4-ethylenedioxythiophene) (PEDOT) 12 
doped with poly[(4-styrenesulfonic acid)-co-(maleic acid)], functionalized with a 13 
bipyridinium derivative and pores are capped with heparin (P3) by electrostatic 14 
interactions. P3 releases the entrapped cargo after the application of -640 mV 15 
voltage versus the saturated calomel electrode (SCE). Pore opening in the 16 
nanoparticles and dye delivery is ascribed to both (i) the reduction of the grafted 17 
bipyridinium derivative and (ii) the polarization of the conducting polymer 18 
electrode to negative potentials that induce detachment of positively charged 19 
heparin from the surface of the nanoparticles. Biocompatibility and cargo 20 
release studies were carried out in HeLa cells cultures.  21 
Keywords  22 
controlled release, electro-responsive, voltage-gated MSNs, conducting 23 
polymers, PEDOT  24 
1. Introduction 1 
Research in the area of gated materials for applications in controlled 2 
release protocols has boosted in the last few years [1-3]. These hybrid materials 3 
are mainly composed by two subunits namely (i) an inorganic porous scaffold in 4 
which a cargo is loaded and (ii) capping molecular or supramolecular 5 
ensembles grafted onto the external surface of the material that can be opened 6 
upon the application of selected external stimuli [4-7]. Depending on the gated 7 
ensemble, cargo release can be triggered in these hybrid materials by stimuli 8 
such as pH changes, redox reactions, light, temperature, ultrasounds, and the 9 
presence of enzymes or (bio)molecules [8-13]. In fact, the possibility to deliver 10 
the cargo on-command upon the presence or application of a certain stimulus is 11 
an important issue in the design of delivery systems, in contrast with passive 12 
delivery, where cargo is released usually by simple diffusion or after a 13 
degradation of the carrier [14-16]. 14 
Among stimuli studied to induce cargo release in gated materials, the use 15 
of redox processes has been widely explored [17-19]. For instance, redox 16 
stimuli have been broadly used for the preparation of gated materials with 17 
applications in controlled release protocols in cells based in the presence of 18 
high intracellular concentrations of reducing agents such as glutathione. Using 19 
this and similar approaches, a number of examples of redox-responsive capped 20 
nanoparticles have been described [20-23]. In contrast, there are only few 21 
examples in which cargo delivery from mesoporous silica nanoparticles (MSNs) 22 
is induced by the application of a voltage. In this area, reported examples 23 
involve the use of MSNs functionalized with ferrocene derivatives and capped 24 
by an inclusion complex formed between a grafted ferrocene derivative and β-25 
cyclodextrin (β-CD) [24-27]. However, the use of these ferrocene-based system 1 
in biological applications is somehow limited due to the relatively high potential 2 
needed (ca. 1-1.5V) to induce ferrocene oxidation and cargo delivery. 3 
From another point of view, conducting polymers are a class of organic 4 
materials with electrical properties similar to those of inorganic semiconductors 5 
and metals [28]. Moreover, the possibility to assemble these polymers into 6 
supramolecular structures has boosted their use in myriads of applications such 7 
as organic solar cells [29], printing electronic circuits [30], organic light-emitting 8 
diodes [31], etc. One of the most appealing uses of conducting polymers is 9 
perhaps their potential application in biomedicine [32,33]. For instance, these 10 
polymers have been used, among other applications, as biosensors [34], 11 
bioactuators [35], neural interfaces [36-38], drug delivery systems [39,40], 12 
tissue engineering scaffolds [41,42], etc. As drug delivery systems, conducting 13 
polymers have been loaded with different molecules that are released upon the 14 
application of an electric potential. Usually, drug delivery process is based in the 15 
change of different redox states of the polymers. These changes results in 16 
discharge of the dopant molecules from the materials to the bulk solution [43-17 
45]. However, conducting polymers as drug release materials are far from being 18 
ideal and several limitations have prevented their wide use in controlled release 19 
applications. For instance, conducting polymers have a limited drug loading 20 
capacity, the range of drugs that can be used is restricted due to charge and 21 
size requirements and show the inherent release of poorly adsorbed 22 
(bio)molecules even without the application of an electric stimulus. Moreover, 23 
although it has been reported that drugs delivered from conducting polymers 24 
could be suitable for local delivery applications [46,47], the amount of drug 25 
delivered should still be increased for their applications in a majority range of 1 
diseases. 2 
A possibility to overcome these drawbacks is to combine conducting 3 
polymers with on-command delivery particles with inherent high-loading 4 
capacity. The benefits to develop these systems set up the basis of smart 5 
materials able to keep applications of conducting polymers (such as 6 
monitorization, electrostimulation, etc.) with the additional ability to release the 7 
cargo upon the application of a selected stimulus. In this way, the biological 8 
applicability of conducting polymers could be enlarged in fields such as neural 9 
regeneration and others in which drug delivery can be finely tuned to provide 10 
selective control of glial and neuronal cell biology [48]. 11 
The high-encapsulation capacity, biocompatibility and the ability of gated 12 
MSNs to release different cargos on demand, makes them ideal carriers to be 13 
combined with conducting polymers. However, the implementation of MSNs 14 
onto conducting polymers is a scarcely studied field and, as far as we know, 15 
only one example with polypyrrole has been described [49]. In this example, 16 
MSNs were loaded with a nerve growth factor, deposited onto polypyrrole and 17 
the effect of drug diffusion in combination with polymer electrical stimulation 18 
was studied in PC12 cells. MSNs were used only as carrier to improve the host 19 
capacity of the polymer and protection of the molecule, but are not stimuli 20 
responsive. Bearing in mind the concepts described above, herein, we present 21 
the design, preparation and characterization of a composite based on the 22 
combination of poly(3,4-ethylenedioxythiophene) doped with poly[(4-23 
styrenesulfonic acid)-co-(maleic acid)] (PEDOT:PSS-co-MA) conductive 24 
polymer and MSNs that are triggered by voltage stimuli (composite P3). MSNs 25 
are loaded with rhodamine B (Rh B, as model molecule) and anchored to the 1 
PEDOT:PSS-co-MA conducting polymer. The external surface of the 2 
nanoparticles is functionalized with a bipyridinium positively charged derivative 3 
and the pores capped upon addition of the negatively charged polysaccharide 4 
heparin. P3 is able to release Rh B by the application of a voltage. Pore 5 
opening and Rh B release in the nanocomposite is ascribed to both (i) the 6 
reduction of the bipyridinium derivative grafted onto the external surface of the 7 
nanoparticles and (ii) the polarization of the conducting polymer electrode to 8 
negative potentials. These factors induces the detachment of negatively 9 
charged heparin from the surface of the nanoparticles allowing cargo delivery. 10 
Besides, P3 films are used for the controlled release of Rh B in cell cultures of 11 
HeLa cells in order to corroborate the application of the system and its 12 
biocompatibility. 13 
 14 
2. Results and discussion. 15 
2.1. Design and characterization of voltage-responsive nanoparticles 16 
The main objective of this paper is to develop a new nanocomposite by 17 
the covalent anchoring of redox-triggered gated mesoporous silica 18 
nanoparticles (S3) onto PEDOT:PSS-co-MA conductive polymer. For this 19 
purpose, in a first step, S3 nanoparticles were prepared and the release of an 20 
entrapped cargo upon the application of a voltage was studied. In a second 21 
step, S3 was covalently attached onto the conductive polymer yielding 22 
nanocomposite P3. Application of an external potential induced cargo release 23 
from the nanoparticles on P3. 24 
The voltage-responsive MSNs S3 are depicted in Scheme 1. Surface of 1 
rhodamine B loaded MSNs was functionalized with a positively charged N,N’-2 
dimethyl-4,4’-bipyridinium derivative (also known as paraquat or methyl 3 
viologen) and capped with the negatively charged polysaccharide heparin via 4 
electrostatic interactions. Methyl viologen was selected because its well-known 5 
redox properties and easy reduction at relatively low potentials (vide infra) 6 
[54,55]. Moreover, heparin (a sulfonated polysaccharide) is a biocompatible cap 7 
that for instance has been used to improve neuronal growth, cell proliferation 8 
and migration [56,57]. The electrostatic interaction between bipyridinium 9 
derivate and heparin on the external surface of the nanoparticles is expected to 10 
inhibit cargo release. In contrast, reduction of bipyrinium by applying a voltage 11 
will induce loss of its positive charge, which would result in a weakening of 12 
electrostatic interaction with the negatively charged heparin, the detachment of 13 
the polysaccharide from the surface and Rh B release.  14 
 1 
Scheme 1. Schematic representation of the synthesis of voltage-responsive S3 nanoparticles. 2 
MSNs are loaded with Rhodamine B (S0) and functionalized with (3-iodopropyl) 3 
trimethoxysilane (S1). The obtained nanoparticles are reacted with 1 by nucleophilic substitution 4 
to yield S2. Finally, nanoparticles were suspended in heparin PBS solution, yielding the final 5 
heparin-capped solid (S3).  6 
MSNs as made and calcined MSNs together with solids, S1, S2 and S3 7 
were characterized using standard techniques. Contents of Rh B, 3-iodopropyl, 8 
bipyridinium dication and heparin for the studied solids were determined by 9 
TGA, elemental analysis and ICP-MS (Table 1, Supporting Information and 10 
















































mesoporous silica materials with four low-angle peaks characteristic of a 1 
hexagonal-ordered pore array indexed as (100), (110), (200) and (210) Bragg 2 
reflections. The (100) reflection is still observed in the PXRD pattern of S1, S2 3 
and S3 (Figure 1, c-e), which evidences that the mesoporous scaffold was 4 
maintained in the final nanoparticles. TEM analysis of the nanoparticles showed 5 
alternated black and white stripes and a pseudo-hexagonal array of pores, 6 
typical of mesoporous systems (Figure 1, right). 7 
  8 




dye 3-iodopropyl bipyridinium heparin 3-aminopropyl
[mmol g
–1
 SiO2] [mmol g
–1
 SiO2] [mmol g
–1
 SiO2] [g g
–1
 SiO2] [mmol g
–1
 SiO2] 
S1 - 0.24 - - - 
S2 - 0.24 0.24 - - 
S3 0.24
a
 0.24 0.24 0.03 - 
S4 0.25
a
 - - - 0.40 
a
 Content of Rhodamine B was only determined in the final solids S3 and S4. 11 
 12 
From N2 adsorption–desorption isotherm studies the total specific surface 13 
of the calcined starting MSNs was calculated to be 1298.3 m2 g-1. Besides, the 14 
calculated pore diameter and pore volume were 2.36 nm and 0.82 cm3 g-1, 15 
respectively. Similar studies on S1 revealed a significant decrease in the N2 16 
volume adsorbed and values of 409.8 m2 g-1 and 0.11 cm3 g-1 were obtained for 17 
the specific surface area and pore volume, respectively (Table S1 and Figure 1 
S5).  2 
 3 
Figure 1. Characterization of the prepared MSNs.  Powder X-ray diffraction (PXRD) patterns of 4 
solids (a) MSNs as synthesized, (b) calcined MSNs, (c) solid S1 (d) solid S2 (e) solid S3 and (f) 5 
solid S4. TEM images of (g) calcined MSNs, (h) solid S3 and (i) solid S4 showing the typical 6 
porosity of the mesoporous matrix. (j) 
1
H-NMR shifts of heparin protons in the presence of 7 
increasing quantities of N,N’-dimethyl-4,4’-bipyridinium diiodide (compound 3, mimicking 8 
bipyridine-heparin interactions) in D2O. 9 
 10 
Moreover, in order to characterize the heparin-bipyridinium interactions, 11 
responsible of the capping mechanism in S3 and P3, 1H-NMR studies were 12 
carried out using heparin solutions in D2O treated with increasing amounts of 13 
N,N’-dimethyl-4,4’-bipyridinium dication (3). 1H NMR spectrum of heparin 14 
showed the typical signals of polysaccharide protons directly linked to hydroxyl 15 
moieties in the 3.6-4.4 ppm range and a broad doublet at ca. 3.31 ascribed to 16 
protons in the sugar backbone directly linked to a sulfonamide group (Figure 17 
1j). Addition of increasing quantities of 3 induced moderate upfield shifts of the 18 
polysaccharide protons (3.5-4.2 ppm) and a remarkable upfield shift for the 19 
proton linked to the sulfonamide unit (from 3.31 to 3.03 ppm). The observed 20 






















shifts are ascribed to interactions between heparin and bipirydinium derivative 1 
3. Based on 1H-NMR titration results, the affinity constant of bipyridine 2 
derivative 3 with heparin was calculated to be (5.7 ± 0.69) x 104. 3 
 4 
Figure 2. Release profiles of Rh B from S3 nanoparticles in PBS at pH 7.5 alone and upon the 5 
application of a -640 mV vs SCE potential. 6 
 7 
For Rh B release experiments from heparin-capped MSNs S3, first we 8 
carried out studies of the redox properties of methyl viologen (compound 3) and 9 
the carboxylic derivative 2. Previous reported studies described that the methyl 10 
viologen dication displays a one-electron reduction at -615 mV vs. SCE [58]. In 11 
our conditions, we found reduction values of -600 mV for 3 and -605 mV vs. 12 
SCE for 2, respectively.  13 
Once electrochemically characterized the methyl viologen derivatives, 14 
controlled Rh B delivery experiments from S3 were carried out in an 15 
electrochemical cell by applying an electric potential of -640 mV vs SCE. The 16 





















































potential of -640 mV vs. SCE was selected considering the electrochemical 1 
studies carried out on molecule 3 (vide ante). The release profiles from S3 are 2 
shown in Figure 2. In absence of electric potential a low Rh B release was 3 
observed (ca. 7% of the maximum Rh B delivered after 60 min), however, when 4 
a continuous -640 mV vs. SCE potential was applied a marked dye release was 5 
found that reached its maximum after only 30 min. Moreover, similar delivery 6 
profiles were observed when PBS suspensions of S3 were treated with the 7 
reducing agent acetaldehyde (Figure S6), which strongly suggests that Rh B 8 
delivery was due to the reduction of the grafted bipyridinium. As explained 9 
above, reduction of bipyridinium induces a decrease in the positive charge of 10 
this molecule, which weakens the electrostatic interaction with the negatively 11 
charged heparin, overall resulting in a detachment of the polysaccharide from 12 
the surface of the nanoparticles and cargo release. This detachment of heparin 13 
from S3 was assessed in additional experiments. Thus, sulfur content (by ICP-14 
MS) in solution was determined when S3 nanoparticles were suspended in 15 
water in the presence and in the absence of the electrochemical stimuli (both, a 16 
voltage of -640 vs. SCE or addition of acetaldehyde). Whereas sulfur content in 17 
solution was negligible in the absence of stimuli, an important increase of sulfur 18 
(due to heparin) was found upon application of the electrochemical stimuli.  19 
 20 
2.2 Design and characterization of voltage-responsive PEDOT:PSS-co-MA 21 
composites bearing heparin-gated nanoparticles  22 
For the preparation of the bipyridinium-heparin gated nanoparticles we 23 
used MSNs (S0) and functionalized them with (3-aminopropyl) triethoxysilane in 24 
order to obtain S4. PEDOT:PSS-co-MA polymer was electro-synthesized on 25 
Au-coated surfaces (P0). Then, S4 nanoparticles (loaded with Rh B and 1 
functionalized with aminopropyl moieties) were covalently attached onto the 2 
PEDOT:PSS-co-MA polymer through the formation of amide bonds (P1). Once 3 
S4 nanoparticles were assembled onto the polymer, the unbounded surface of 4 
the MSNs was functionalised with N,N’-bypiridinium-1-(carboxymethyl)-1’-5 
methyl diiodide (2) yielding P2 films. The final material (P3) was obtained by 6 
capping the grafted nanoparticles containing positively charged bipyridinium 7 
moieties with heparin by electrostatic interactions. Scheme 2 shows the 8 
synthetic procedure used for the preparation of material P3.  9 
  1 
Scheme 2. Synthesis of PEDOT:PSS-co-MA films containing heparin-capped MSNs (P3). 2 
MSNs are loaded with Rh B and functionalized with (3-aminopropyl) trimethoxysilane (S4). 3 
PEDOT:PSS-co-MA material was immersed in an EDC/sulfo-NHS MES buffer solution (pH = 6) 4 
in order to activate carboxylic groups. Then, S4 nanoparticles were added in order to obtain P1 5 
material. After that, carboxylic acid of 4,4’-bypiridinium-1-(carboxymethyl)-1’-methyl diiodide was 6 
activated and then P1 was immersed into the solution yielding P2. Finally, heparin was 7 
































































































































PXRD pattern (Figure 1f) and TEM image (Figure 1i) of S4 showed the 1 
typical features of mesoporous silica nanoparticles. Besides, from N2 2 
adsorption-desorption measurements, values of specific surface, pore diameter 3 
and pore volume of 43.4, 2.36, and 0.07, respectively were determined for S4 4 
(Table S1). Attachment of the capped MSNs S4 on the PEDOT:PSS-co-MA 5 
polymer was assessed by FESEM-FIB (Figure 3). FESEM-FIB images of P0 6 
(Figure 3a and 3b) showed a surface with no irregularities and a smooth 7 
morphology, whereas in images of P3 (Figure 3d and 3e) spherical MSNs 8 
homogeneously distributed over the entire surface were found confirming the 9 
attachment of the nanoparticles on the PEDOT:PSS-co-MA films. Moreover, 10 
confocal microscopy images of P3 displayed a homogeneously distributed red 11 
emission in comparison with P0 due to the presence of the loaded Rh B in the 12 
attached nanoparticles (Figure 3c and 3f). Rh B and heparin content in the final 13 
P3 film amounted to 0.16 mg and 0.65 mg in 1 cm2 of PEDOT:PSS-co-MA 14 
scaffold, respectively. In addition, modifications in the surface of PEDOT-MSNs 15 
films were confirmed by attenuated total reflectance (ATR) (Figure S7). A typical 16 
OH broad band in the 3630 to 3044 cm-1 range was found in P3. Moreover, 17 
peaks at 1614 cm-1 due to carboxylates and vibrations at 1209 and 1016 cm-1 18 
attributed to symmetric and antisymmetric stretching vibrations of -SO3
- from 19 
heparin were also observed. 20 
P0 and P2 were also characterized by cyclic voltammetry (Figure 3g and 21 
3h). When P0 was used as working electrode a reduction peak at -462 mV was 22 
observed and attributed to the reduction of the PEDOT film. However, when P2 23 
was used as working electrode in the same conditions, a shift of the reduction 24 
peak from -462 to -557 mV was found, which is tentatively attributed to the 25 
presence of the electroactive methyl viologen derivative in the nanoparticles 1 
attached in P2.   2 
 3 
  4 
Figure 3. Characterization of PEDOT:PSS-co-MA containing heparin-capped MSNs. Left: (a) 5 
FESEM-FIB image of P0 surface, (b) FESEM-FIB image of a cross-section of P0, (c) confocal 6 
image of P0. Right: (d) FESEM-FIB image of P3 surface, (e) FESEM-FIB image of a cross-7 
section of P3, (f) confocal image of P3. (g) Cyclic voltammogram of P0 and P2 showing the shift 8 
of the reduction potential from -462 to -557 mV. h) Reduction potential values for the 9 
bipyridinium derivative 2 and the P0 and P2 films.  10 
 11 
Cargo release from P3 films was tested in the absence and after the 12 
application of an external voltage. The cargo release profiles are shown in 13 
Figure 4. In the absence of potential, a low delivery of Rh B was observed (less 14 
than 5% after 30 min). In contrast, a significant release of Rh B was found from 15 
the P3 film when a -640 mV vs. SCE potential was applied (ca. 90% of the total 16 
dye release after 15 min). Again, as for S3 nanoparticles (vide ante), pore 17 


































h) Reduction potential of materials
2 P0 P2
-615mV -462mV -557mV
bipyridinium derivative and heparin detachment. Besides, for P3, the 1 
concomitant reduction of the conducting polymer and its polarization to negative 2 
potentials may also help to induce detachment of the negatively charged 3 
heparin (due to electrostatic repulsion) from the surface of the nanoparticles. 4 
Release studies also revealed that ca. 2 µg of cargo/cm2 of scaffold were 5 
delivered from P3, which is ca. 2- to 4-fold larger than typical amounts delivered 6 
in reported conducting polymers for drug release applications [46,47]. Similar 7 
delivery profiles were found when PBS suspensions of P3 were treated with the 8 
reducing agent acetaldehyde (Figure S8), strongly suggesting that Rh B 9 
delivery is redox-controlled. These experiments demonstrate that the modified 10 
PEDOT:PSS-co-MA conducting polymer P3 is able to show poor cargo release, 11 
yet able to deliver the payload at will upon application of an external voltage. 12 
 13 
Figure 4. Release profiles of Rh B from P3 films in PBS at pH 7.5 alone and upon the 14 
application of -640 mV vs SCE.  15 


































































In an attempt to further advance in the potential application of P3 we 1 
tested its biocompatibility and the possibility of using the film to deliver a cargo 2 
(i.e. Rh B) by simply applying an external electric voltage to cells in a cell 3 
culture medium. To determine biocompatibility, P0 and P3 were compared in 4 
terms of their ability to support cell growth and proliferation. Moreover, as 5 
positive control group, cells were also seeded onto the well-plate surface. 6 
Biocompatibility was determined at 48, 72 and 96 h by using the WST-1 assay. 7 
Phase contrast microscopy images showed healthy looking adherent cells onto 8 
the surface of both, P0 and P3 (Figure 5a and 5b) films, this images are in 9 
concordance with the viability result obtained after 96 h (Figure 5c), where no 10 
significant cell death was observed in the PEDOT-based P0 and P3 films. 11 
 12 
 13 
Figure 5. Phase contrast microscope image of HeLa cells on (a) P0 and (b) P3 films. (c) Cell 14 
viability of HeLa cells seeded onto well-plate surface (control), on P0 and P3 after 48, 72 and 96 15 
h. The data represent the mean ± SEM and statistical significance was determined using a one-16 
way ANOVA to compare the different sample groups at predetermined time (* p < 0.05, ** p < 17 
0.025, *** p < 0.001). No significate change can be observe between the different material (P0 18 





































Moreover, Rh B release studies from the voltage-responsive P3 composite 1 
was tested in the presence of HeLa cells. HeLa cells were seeded over P3 films 2 
that were used as working electrode. A continuous voltage of -600 mV vs. Ag-3 
AgCl was then applied for 15 min and Rh B followed by confocal microscopy. 4 
Confocal images of Rh B delivered from P3 and finally internalized by HeLa 5 
cells are shown in Figure 6a. In the absence of potential applied the presence of 6 
Rh B inside HeLa cells was negligible after 24 h (t=0). However, after 15 min of 7 
voltage application, Rh B emission in HeLa cells was observed with the 8 
fluorescence intensity inside cells clearly increasing with time (Figure 6b). Rh B 9 
controlled release from P3 in cell culture was also checked after addition of 10 
acetaldehyde as chemical reducing agent (Figure S9) with similar results, 11 
strongly suggesting that the Rh B uptake by HeLa cells was ascribed to the 12 
voltage-induced Rh B release. These studies demonstrated that the cargo (i.e. 13 
Rh B) remained inside the nanoparticles in P3 even in a complex cell culture 14 
medium. Besides, after the delivery experiment FESEM-FIB images of the P3 15 
films (Figure S10) showed that MSNs remained attached onto the polymeric 16 
backbone, indicating that it is the cargo but not the nanoparticles that are 17 
delivered from P3.  18 
 1 
Figure 6. (a) Confocal microscopy images of cellular controlled release studies with P3.  HeLa 2 
cells were examined after 24 h of seeding (t = 0) and upon the application of a continuous -600 3 
mV vs Ag-AgCl potential at t = 15 min, 2 h and 4 h. Rh B associated fluorescence is in red and 4 
the cellular nucleus marked with Hoechst 33342 in blue. (b) Ratio of mean fluorescence 5 
intensity (If/I0) of Rh B signal in HeLa cells (Image J software analysis) upon the application of a 6 
continuous -600 mV vs Ag-AgCl potential at t = 15 min, 2 h and 4 h to film P3. 7 
 8 
With an aging population and the afflictions of fatal diseases, the 9 
development of tools for tissue-engineering and regenerative medicine is of 10 
great importance. In this field, the design of conducting polymers with new 11 
functionalities is becoming a topic of growing interest. However, their use for 12 
drug delivery have some drawbacks such as low loading ability and a poor 13 
range of cargos that can be used. To overcome these limitations, we 14 
demonstrate that it is possible to combine conducting polymers with gated 15 
MSNs able to deliver a cargo upon the application of a voltage. The obtained 16 
results prove the use of PEDOT-MSNs films in controlled drug delivery 17 


































MSNs films could be used to both, as neuro–electronic interfaces and lesion-1 
bridging systems and to deliver specific molecules, for uses in nervous system 2 
lesions or spinal cord injury. In these scenarios, neuroprotection and 3 
regeneration could be promoted by delivering neural growth factors or drugs 4 
that enhance the bioactivity of the substrate and enhance cellular growth and 5 
axonal elongation [59]. Besides, PEDOT-MSNs films could help in therapy of 6 
neurological disorders, such as Parkinson, by stimulating deep brain regions as 7 
well as by delivering drugs (dopamine, L-DOPA, etc.) [60]. 8 
Some other applications combining electrical stimulation as well as drug 9 
release can also be envisioned enhancing the opportunities for tissue repair or 10 
for the development of electro-active prostheses for voltage-controlled drug 11 
delivery. Thus, conducting polymers have also been used in studies for cardiac 12 
muscle regeneration [61]. PEDOT-MSNs could act as electrical nanobridge, by 13 
transferring electrical signals between cardiomyocytes and delivering bioactive 14 
molecules to promote the recovery of damaged cardiac cells. Otherwise, 15 
PEDOT-MSNs looks promising in bone tissue regeneration and wound healing 16 
applications. Electrostimulation, combined with drug delivery from MSNs, could 17 
be used for promoting faster mineralization or healing by releasing bioactive 18 
molecules for mineralization as well as antimicrobials or anti-inflammatory drugs 19 
to control bone or skin infection [62]. However, further research is needed to 20 
evaluate the potential application of these new materials and studies for specific 21 
uses are currently studied by us. Besides, voltage-triggered gated MSNs can be 22 
easily adapted to the development of new films attending the easy surface 23 
functionalization of MSNs, which opens the possibility to attach the 24 
nanoparticles to other conductive polymers. Moreover, gated nanoparticles can 25 
also be designed to respond to positive or negative potentials attending the 26 
electrical properties of the selected polymer and their applications. We believe 1 
that the results presented herein might inspire the development of new films 2 
equipped with gated MSNs for a number of uses in the pharmaceutical and 3 
biomedical field. 4 
3. Conclusions 5 
We demonstrate herein that it is possible to combine conducting polymers with 6 
gated MSNs able to deliver a cargo upon the application of a voltage. In 7 
particular, we prepared MSNs loaded with rhodamine B and capped by an 8 
electro-active shell formed by grafted bipyridinium cations and heparin. In the 9 
absence of an external voltage heparin-coated MSNs (S3) are unable to release 10 
the entrapped dye. However, upon the application of a continuous -640 mV vs. 11 
SCE potential a marked cargo release is observed. This delivery is ascribed to 12 
the reduction of the bipyridinium dication that induced heparin detachment and 13 
subsequent pore opening. This mechanism is demonstrated with the addition of 14 
acetaldehyde as a chemical reducing agent. We also prepared PEDOT:PSS-co-15 
MA conducting polymers in which the capped nanoparticles are covalently 16 
attached (P3 films). The prepared films are able to release the entrapped 17 
rhodamine B upon the application of a -640 mV vs. SCE voltage. Cell 18 
proliferation studies carried out with HeLa cells show that P3 films are 19 
biocompatible. Besides, the application of a -600mV vs. Ag-AgCl voltage, 20 
induced rhodamine B release from the grafted MSNs, which are uptake by 21 
HeLa cells. To the best of our knowledge, P3 is the first example of a PEDOT-22 
based conducting polymer equipped with gated MSNs. P3 shows a remarkable 23 
cargo delivery triggered by the application of an electric potential. Our studies 24 
also open the concept to develop conducting polymers combined with capped 25 
MSNs for the on-command delivery of selected cargos using different stimuli for 1 
a number of different applications.    2 
 3 
4.  Experimental section 4 
4.1. Synthesis of MSNs materials and S3 preparation 5 
Detailed materials and experimental section for (S3) nanoparticles 6 
obtaining are included in the supporting information. The starting MSNs were 7 
synthetized following well established procedures as previously reported 8 
[50,51]. Once obtained the starting material, rhodamine B loaded nanoparticles 9 
(S0), functionalized (S1 and S2) and capped with heparin (S3) were prepared.  10 
4.2. Synthesis of N-methyl-4,4’-bypiridinium iodide (1) 11 
4,4´-bipyiridine (3.0 g, 19.3 mmol) was transferred to a two-necked round 12 
bottom flask equipped with a condenser. Anhydrous CH3CN (120 mL) was 13 
added and the system was purged with Argon. Once the solution was at reflux, 14 
methyl iodide (1200 µL, 19.3 mmol) was added dropwise and the reaction was 15 
maintained at reflux for 12 h. Finally, the solvent was removed under reduced 16 
pressure. Product was purified by washing with cold methanol to precipitate the 17 
dimethylated compound. Methanol was removed under reduced pressure in 18 
order to obtain product (1) as an orange solid in 93.9% yield (5.39 g, 18.12 19 
mmol). 1H NMR (400 MHz, D2O) δ = 8.93 (d, J = 6.7 Hz, 2H), 8.78 (dd, J = 4.6, 20 
1.6 Hz, 2H), 8.40 (d, J = 6.6 Hz, 2H), 7.92 (dd, J = 4.6, 1.4 Hz, 2H), 4.47 (s, 3H) 21 
ppm. 13C NMR (400 MHz, D2O) δ = 153.45, 149.98, 145.62, 142.57, 125.77, 22 
122.48, 47.90 ppm. HRMS-EI m/z: calcd for C11H11N2
+: 171.0917; measured: 23 
171.0914. (Figure S1). 24 
4.3. Synthesis of 3-aminopropyl functionalized MSNs (S4) 1 
For the preparation of S4, 150 mg of MSNs loaded with rhodamine B (S0) 2 
were suspended in a saturated solution of Rh B in anhydrous CH3CN (6 mL). 3 
Then, an excess of (3-aminopropyl) trimethoxysilane (175.50 µL, 5 mmol/g 4 
solid) was added, and the final mixture was stirred at room temperature for 5.5 5 
h. The resulting pink solid (S4) was isolated by centrifugation, washed twice 6 
with CH3CN (5 ml) and dried at 37°C. 7 
4.4. Synthesis of PEDOT:PSS-co-MA (P0) 8 
An Autolab PGstat30 galvanostat/potentiostat was used for PEDOT:PSS-9 
co-MA electro-polymerization at constant anodic current (100 µA/Cm2, 96 10 
mC/cm2 polymerization charge) on gold-coated glass slides. A Pt foil served as 11 
counter-electrode and a SCE as reference electrode. The solution for 12 
electrodeposition contained 0.16 % (v/v) 3,4-ethylenedioxythiophene (EDOT) 13 
and 0.344 % (w/v) PSS-co-MA in aqueous potassium phosphate-buffered saline 14 
(Milli-Q water with 18.2 MΩ cm2 containing 9 g NaCl, 0.8 g Na2HPO4·2H2O and 15 
0.14 g KH2PO4 per liter) [52]. 16 
4.5. Synthesis of PEDOT:PSS-co-MA films containing MSNs (P1) 17 
In a first step, carboxylic groups on the surface of PEDOT:PSS-co-MA 18 
were activated with a solution of 10 mg/mL of EDC (15 ml) and 10 mg/mL of 19 
sulfo-NHS (5 mL) in MES buffer (pH = 6) for 15 min at room temperature. Then 20 
20 mg of S4 nanoparticles were suspended in 5 ml of PBS buffer (pH = 7.4) and 21 
activated PEDOT:PSS-co-MA was immersed in the suspension. The reaction 22 
was stirred overnight in order to covalently attach MSNs to PEDOT:PSS-co-MA, 23 
giving P1. The final material was washed twice with PBS. 24 
4.6. Synthesis of 4,4’-bypiridinium-1-(carboxymethyl)-1’-methyl diiodide 1 
(2) 2 
Product 2 was synthesized by nucleophilic substitution reaction between 1 3 
and ethyl bromoacetate. Compound 1 (1.6 g, 5.38 mmol) was transferred to a 4 
two-necked round bottom flask equipped with a condenser. Then, anhydrous 5 
acetonitrile (18 mL) was added and the system was purged with Argon. Once 6 
the reaction was at reflux, ethyl bromoacetate (1500 µl, 12.15 mmol) was added 7 
dropwise and the reaction was maintained at reflux for 5 h. Finally, the solid 8 
product obtained was filtered off and washed three times with acetonitrile. The 9 
intermediate ester was stirred in 200 mL of NaOH 1 M for 10 min and then the 10 
solution was acidified until pH = 2 in order to hydrolyze the ester group. The 11 
final product was purified by washing with cold methanol. 2 was obtained as an 12 
orange solid in 90.2% yield. (1.12 g, 4.85 mmol). 1H NMR (400 MHz, D2O) δ 13 
9.05-9.02 (m, 4H), 9.02 (d, J = 6.97 Hz, 2H), 8.54 (d, J = 6.73 Hz, 2H), 5.56 (s, 14 
2H), 4.55 (s, 3H). 13C NMR (101 MHz, D2O) δ 169.34, 150.75, 149.76, 146.70, 15 
146.35, 126.80, 126.75, 62.28, 48.43. HRMS-EI m/z: calculated for 16 
C13H15N2O2
2+: 231.1123; measured: 231.1161. (Figure S2). 17 
4.7. Synthesis of PEDOT:PSS-co-MA films containing heparin capped-18 
MSNs (P3) 19 
Covalent attachment of 2 was carried out through the formation of an 20 
amide bond between the carboxylic group in 2 and free amino moieties in MSNs 21 
yielding P2. For this purpose, the carboxylic group in 2 (73.5 mg, 0.2 mmol) was 22 
activated with a solution of 10 mg/mL of EDC (15 ml) and 10 mg/mL of sulfo-23 
NHS (5 ml) in MES buffer (pH = 6) for 15 min at room temperature. Then pH 24 
was adjusted to 7.4, P1 was immersed into the solution and the mixture was 25 
stirred overnight. The final material was washed twice with PBS. Finally, heparin 1 
(20 mg, 0.015 mmol) was dissolved in 5 ml of PBS (pH = 7.4) and P2 was 2 
immersed in the solution. After 3 h at room temperature, the final electro-3 
responsive material P3 was obtained, washed with PBS (pH = 7.4) and dried at 4 
room temperature. 5 
4.8. Bypiridinium-heparin interaction studies 6 
In order to assess the interaction between bypiridinium derivatives and 7 
heparin, involved in the capping mechanism of S3 and P3,1H-NMR studies in 8 
D2O were carried out using compound 3 (0.1 M) (Figure S3) and heparin (20 9 
mg/mL). 1H-NMR signals of heparin were monitored after the addition of 10 
increasing quantities of 3 (from 0.2 to 1.1 eq.). 11 
4.9. Cargo release studies with S3 and P3 12 
In a first step, for the Rh B release experiments of heparin-capped MSNs 13 
S3, we carried out studies of redox properties of methyl viologen (compound 3) 14 
and the carboxylic derivative 2 at room temperature with a 15 
potentiostat/galvanostat reference PGSTAT100 (Autolab) connected to a PC 16 
using an electrochemical cell containing a stainless steel working electrode, a 17 
Pt ring counter electrode and a calomel electrode as reference.  18 
Controlled Rh B delivery from S3 were carried out at room temperature 19 
with a potentiostat/galvanostat reference PGSTAT100 (Autolab) connected to a 20 
PC using an electrochemical cell with a stainless-steel working electrode 21 
(diameter 30 mm, thickness 2 mm), a Pt ring electrode (Crison) as counter 22 
electrode and a SCE (Crison) as reference. In a common experiment, 4 mg of 23 
solid S3 were suspended in 12 mL of PBS (10 mM, pH 7.5) in the 24 
electrochemical cell. Release of Rh B from S3 was studied with and without the 1 
application of stimuli (-640 mV vs. SCE potential). At certain fixed times, 2 
aliquots were separated, centrifuged to eliminate the solid, and the Rh B 3 
released from S3 was monitored following the emission band at 576 nm (ex = 4 
554 nm). 5 
Once performed the delivery studies with S3, we move one step forward to 6 
monitor the release of Rh B from the heparin-capped nanoparticles grafted onto 7 
the PEDOT:PSS-co-MA film (P3). The experiments were performed with the 8 
potentiostat/galvanostat reference PGSTAT100 using an electrochemical cell 9 
with P3 acting as working electrode. The Pt ring electrode (Crison) was used as 10 
counter electrode and a SCE (Crison) as reference. P3 was immersed in 12 mL 11 
of PBS (10 mM, pH 7.5). The release of rhodamine B was registered at certain 12 
fixed times, in the absence and upon the application of a -640 mV vs. SCE 13 
potential. Similar experiments were carried out using (500 µl) acetaldehyde as 14 
chemical reducing agent in a similar procedure for S3 and P3 respectively. The 15 
100% release was determinate in each experiment by normalizing to the 16 
maximum Rh B release achieved (% rhodamine B released = RhB sample/RhB 17 
max *100) 18 
4.10. Cell culture conditions 19 
HeLa human cervix adenocarcinoma cells were purchased from the 20 
German Resource Centre for Biological Materials (DSMZ) and were growing in 21 
DMEM supplemented with 10% FBS. Cells were incubated at 37°C in an 22 
atmosphere of 5% carbon dioxide and 95% air and underwent passage twice a 23 
week. 24 
4.11. Cell proliferation studies 1 
P0 and P3 films were first sterilized by exposure to UV light for 30 min and 2 
were placed in a 6-well plate. HeLa cells were seeded onto the films at 200,000 3 
cells/mL in DMEM with 10% FBS. Cell viability before starting the experiment 4 
was determined by the Trypan Blue method, and the measured viability 5 
exceeded 95% in all cases. After 48 h the cell growth was tested by adding the 6 
cell proliferation WST-1 reagent for 1 h. After 1 h, 100 μl of the medium 7 
containing the WST-1 reagent was placed in a 96-well plate, and the 8 
absorbance was measured at 595 nm in a Wallac 1420 workstation. Then, cells 9 
were washed with PBS and fresh medium was added. This process was 10 
repeated after 72 and 96 h. 11 
4.12. Controlled release of P3 in cell cultures of HeLa cells 12 
P3 was placed over glass coverslip in a 6 well-plate and then cells were 13 
seeded and incubated at 37 °C for 24 h in DMEM. After 24 h of incubation, cells 14 
were washed with PBS, and the DNA marker Hoechst 33342 (2 µg/mL) was 15 
added to visualize the cells seeded onto P3 using a confocal microscope (Leica 16 
TCS SP8 AOBS). After the evaluation of the cells at 0 min, electrical stimulation 17 
was performed using a previously validated homemade electronic equipment 18 
designed based on the previously reported FraPlus Mini system [53]. The 19 
electrochemical cell included P3 as working electrode, a Pt (1 mm Ø) electrode 20 
as counter electrode and a Ag-AgCl (1 mm Ø) homemade electrode as 21 
reference electrode). These electrodes overcame the spatial restriction of being 22 
introduced in the 6 well-plate. The applied potential was -600 mV vs. Ag-AgCl  23 
(-640 mV vs. SCE). After the application of the potential Rh B released and 24 
internalized in cells was monitored by confocal microscopy. Release 25 
experiments were also carried out using acetaldehyde as chemical reducing 1 
agent. 2 
 3 
ACKNOWLEDGMENTS. Alba García-Fernández, Beatriz Lozano-Torres 4 
contributed equally to this work. A. García-Fernández and B. Lozano-Torres are 5 
grateful to the “Ministerio de Economía y Competitividad” of the Spanish 6 
Government for her PhD fellowships. J. F. Blandez thanks the “Universitat 7 
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